26 Mar
2021

Filings show Chinese gene sequencer BGI has paid out millions in legal fees battling Illumina over patents

Overseas patent risks and litigation costs might impact Chinese firms seeking public listing on the high tech board of the Shanghai Stock Exchange. BGI is not the first Chinese tech company whose patent expenses have come under great scrutiny.

Bing Zhao

Author | China editor

[email protected]

Bing Zhao